患有轻度喘的成年人急性喘恶化的危险因素
Wansu Chen1, Eric J Puttock1, Michael Schatz2
1Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, Calif.
概括
在轻度喘患者中确定了急性喘恶化 (AAE) 的危险因素. 年龄,性别,吸烟,肥胖和并发症显著预测了未来的AAE风险,突出了扩大管理策略的必要性.
科学领域:
- 肺部病理学 肺部病理学
- 流行病学 流行病学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 轻度喘占急性喘恶化 (AAE) 的很大一部分,但风险因素仍未得到充分研究.
- 了解这些因素对于这种流行群体的有效喘管理至关重要.
研究的目的:
- 在被诊断为轻度喘的成年患者中,识别和分析与急性喘恶化 (AAE) 相关的风险因素.
- 这项研究旨在为预防该群体的AAE提供有针对性的干预措施.
主要方法:
- 一项回顾性队列研究,利用来自大型管理护理组织的行政数据.
- 在2013年至2018年期间,分析了199,010名患有轻度喘的成年患者,以确定在随后一年内发生AAE的预测因素.
- 用波松回归模型计算未来AAE的调整风险比率.
主要成果:
- 研究队列 (n=199,010) 的平均年龄为44岁,64%是女性;6.5%在一年内经历了AAE.
- 多变量分析揭示了未来AAE风险的显著预测因素,包括年龄,性别,种族,种族,吸烟状态,体重指数,先前的急性喘护理和各种并发症.
- 这些临床特征共同影响了经历急性喘恶化的可能性.
结论:
- 目前基于人口的喘管理策略应扩大,包括轻度喘患者.
- 将轻度喘患者纳入管理计划是减少急性恶化总体负担的必要条件.
- 对轻度喘患者的具体干预措施进行进一步的研究是有必要的.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma: Pathogenesis and Management
386
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
386
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: β2-Adrenoceptor Agonists
249
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
249


